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DECOMPRESSION SICKNESS (DCS) is a systemic pathophysiological process that occurs as a result of transit from higher to lower ambient pressure. It is a risk associated with compressed gas diving and tunneling, high-altitude aviation, and space exploration. Gas bubbles, long thought to be an inciting factor for DCS, are often asymptomatic and may occur as a consequence of most decompression events (2, 6, 7) . Hence, additional factors are involved in DCS pathophysiology. There is now considerable evidence that circulating microparticles (MPs) are elevated in associated with simulated and bona fide underwater diving; moreover, maneuvers that decrease the incidence of DCS also diminish MP production (8 -10, 12, 19, 20, 23) . With these issues in mind, this investigation sought to better understand the factors that trigger production of MPs in a murine DCS model.
MPs are membrane-encapsulated cell fragments with diameters of 0.1 to 1 m. Most MPs have annexin V on the surface because phosphatidylserine becomes exposed on the outer membrane leaflet during formation. MPs are found in healthy humans and are increased in association with a large number of pathological conditions (3, 5, 13, 21, 24) . Murine studies suggest that MPs play a role in decompression pathophysiology and, because some contain a gas phase, they may be involved with gas bubble nucleation (21, 22, 26, 27) . MPs have been shown to initiate a systemic inflammatory process after decompression that is related to neutrophil activation (21, 22, 26, 27) . Injuries identified in decompressed animals can be recapitulated by injecting decompression-induced MPs into naïve mice (22, 26, 27) .
Oxidative stress is known to occur with SCUBA diving and has been documented as an upregulation of antioxidant genes and elevations in plasma and intracellular antioxidant enzyme levels (1, 4, 11, 14 -16) . These changes have been assumed to occur due to elevations in oxygen (O 2 ) partial pressure associated with breathing air at depth. Production of MPs by neutrophils is also an oxidative stress response; however, neutrophils generate MPs when exposed to elevated partial pressures of helium, nitrogen (N 2 ), or argon even when there is no elevation in O 2 partial pressure above that associated with ambient air (18) . This occurs due to singlet O 2 , which is generated by collision complexes between O 2 and inert gases. Singlet O 2 triggers a cascade of cytoskeletal modifications that generate MPs. MP production in mice exposed to high-pressure air can be inhibited by ascorbic acid, an effective singlet O 2 scavenger (25) . Therefore, we hypothesized that elevated N 2 partial pressure, more so than O 2 , was responsible for pathological changes associated with MPs being generated by exposure to high-pressure air.
EXPERIMENTAL PROCEDURES
Materials. Chemicals were purchased from Sigma-Aldrich (St. Louis, MO) unless otherwise noted. Compressed gases were purchased from Air Products and Chemicals (Allentown, PA). Antibodies were purchased from sources as described below.
Animals. All aspects of this study were reviewed and approved by the University of Maryland Institutional Animal Care and Use Committee. C57BL/6J mice (Mus musculus) were purchased from Jackson Laboratories (Bar Harbor, ME), housed in the university animal facility, and fed water ad libitum along with Laboratory Rodent Diet 5001 (PMI Nutritional, Brentwood, MO) for at least 30 days before the study. Mice breathed room air (control) at ambient pressure (100 kPa) or they were subjected to 2-h exposures to 790 kPa air, 166 kPa O 2 gas, or 714 kPa of a gas mixture of 2.98% O2 balanced with pure N 2. These exposures were conducted in a small, highpressure chamber exactly as described in previous publications, except for a slight modification with exposures involving the 2.98% O2 gas (i.e., at the time of decompression the chamber was vented with air rather than the 2.98% O 2/N2 gas mix to avoid an interval of hypoxia) (21, 27) . At 2 or 13 h after decompression, the animals were killed for study.
Standard procedures for MP isolation. All reagents and solutions used for MP isolation and analysis were filtered with 0.1-m filter (EMD Millipore, Billerica, MA). MPs were isolated and prepared for analysis by flow cytometry as previously described. Briefly, heparinized blood was immediately fixed with 100 l/ml of Fixation Medium A (Invitrogen, Carlsbad, CA) and centrifuged for 5 min at 1,500 g. EDTA was added to the supernatant to achieve 12.5 mM to prevent MP aggregation. Plasma was centrifuged at 15,000 g for 30 min, Neutrophil activation analysis. Whole fixed blood (100 l) was stained for 30 min at room temperature in the dark with optimized concentrations of the following antibodies: eFluor 450-conjugated anti-mouse Ly6G (Gr-1), FITC-conjugated anti-myeloperoxidase (MPO) (Abcam, Cambridge, MA), PE-conjugated anti-mouse CD18 (BioLegend), and APC-conjugated anti-mouse CD41 (eBioscience). After staining, 2 ml of PBS was added to dilute each sample tube to analysis, with the cytometer acquisition set to use eFluor 450-conjugated anti-mouse Ly6G as the fluorescence trigger to recognize mouse neutrophils.
Vascular permeability assay. Mice were injected with lysinefixable tetramethylrhodamine-conjugated dextran (2 ϫ 10 6 Da, Invitrogen, Carlsbad, CA) and endothelium-enriched tissue homogenates prepared using colloidal silica following published methods (21, 27) . Vascular permeability, quantified as perivascular dextran uptake in the experimental groups, was normalized to a value obtained with a control mouse included in each experiment.
Statistical analysis. We used Sigmastat software (Systat, Point Richmond, CA) for the statistical analysis. All results were expressed as means Ϯ SE. Neutrophil activation, capillary leak, annexin V-positive particle counts, and subtypes were analyzed by two-way ANOVA with the Holm-Sidak method for multiple comparisons post hoc to evaluate both the impact of pressure/decompression and time from decompression.
RESULTS
MP elevation subsequent to pressurization. Total annexin V-positive MPs and subtypes expressing various vascular proteins are shown in Figure 1 . A statistically significant elevation in total MPs, but not the specific subtypes, was found at 2 h after exposure to high-pressure air. Elevations over those in control animals were found 13 h after exposure to 790 kPa air and to normoxic high-pressure N 2 . Exposure to 166 kPa O 2 resulted on no alterations in MPs.
Neutrophil activation. Neutrophils were identified as being Ly6G-positive cells, and surface expression of MPO and the CD18 component of ␤ 2 integrins were assessed as indices of neutrophil activation. Surface expression of the platelet-specific protein CD41 was assessed as a measure of neutrophilplatelet interaction. As shown in Figure 2 , there was evidence of neutrophil activation on the basis of MPO and CD18 expression at 2 h following exposure to high-pressure air. Elevations were found 13 h after high-pressure air and normoxic high-pressure N 2 , but not after exposure to 166 kPa O 2 .
Vascular permeability. Vascular permeability to rhodaminelabeled dextran was evaluated at 13 h after exposure to each gas. Statistically significant elevations were found in all tissues studied (omentum, skeletal muscle, psoas, and brain) following exposure to 790 kPa air and to normoxic high-pressure N 2 , but not to 166 kPa O 2 (Fig. 3) .
DISCUSSION
Results from this study indicate that 790 kPa air and normoxic high-pressure N 2 cause an elevation in MPs, neutrophil activation, and a vascular leak. Exposure to O 2 at the same partial pressure that occurs with high-pressure air does not trigger these changes. We conclude that MP elevations and the associated neutrophil activation and vascular injury occurring with high-pressure air do not require concurrent elevation of O 2 partial pressure. These results are consistent with ex vivo neutrophil studies (18) . Moreover, they are consistent with findings from murine and human studies in which it appeared that MP production may have occurred at depth rather than being a consequence of decompression (12, 20) .
Contrary to whole-animal experiments, studies with isolated neutrophils could also be performed at high pressure and in the absence of a gas phase (18) . The results demonstrated that although O 2 partial pressure does not have to be greater than what is found at normal ambient atmospheric pressure, it is nonetheless required for MP generation by high-pressure N 2 . Hence, MP elevation and associated events are a novel form of oxidative stress. In this regard, it is also important to note that responses to high-pressure air in the current study are not identical to those observed with normoxic high-pressure N 2 . Elevations in the total number of MPs and neutrophil activation occurred at 2 h with high-pressure air. Thus pathological events evolved more rapidly, and it is likely that the higher O 2 partial pressure in these exposures contributed to the responses. Murine neutrophils exposed ex vivo to normoxic highpressure N 2 for only 30 min continue to generate MPs for at least 4 h (18). Ly6G-bearing MPs were not elevated at 2 h after decompression in this study, but a statistically significant elevation was observed at 13 h after. The mechanism for in vivo MP production could be the same as that for ex vivo exposure, but additional factors such as MP clearance or platelet-neutrophil interactions may modify the apparent responses. For example, some types of MPs can be cleared from the mouse circulation within 1 h (27) . Neutrophil perturbations could give rise to platelet-neutrophil interactions, which result in activating both cell types. Previous studies have demonstrated that the majority of CD41-bearing MPs are derived from activated platelets (21) . The elevation in CD41-bearing MPs at 13 h after high-pressure air and normoxic high-pressure N 2 could have resulted from platelet activation associated with neutrophil-platelet interactions because there was evidence for this process at 13 h after decompression (Fig. 2) .
Postpressure MPs exhibit proteins derived from neutrophils (Ly6G), platelets (CD41), and erythrocytes (Ter119); CD142 (tissue factor), which may come from endothelial cells, monocytes, macrophages, and platelets; and CD31 (platelet endothelial cell adhesion molecule), which is highly expressed at the intercellular junctions of endothelial cells but is also found on the surface of platelets, monocytes, neutrophils, and some types of T cells. We do not yet know whether de novo MP formation occurs with all cell types, and if it does, whether the mechanism is the same as what occurs in neutrophils. It is possible that neutrophil-derived MPs trigger an inflammatory response that sets off MP production by other cells. Moreover, because MPs interact and share surface proteins, finding proteins specific for a particular cell on MPs does not mean that all the MPs were derived from a single cell type (19, 20, 26, 27 ). A causal or direct relationship between MPs and DCS in humans is lacking, and further studies are required. However, our results provide additional insight into high-pressure gas pathophysiology. Manipulations that diminish MP production are also known to reduce the risk for DCS; therefore, further study may lead to improved safety of provocative dive profiles (8, 9) . Ascorbic acid administration inhibits MP elevation and tissue injuries in mice, and also diminishes MP elevation and neutrophil activation in human divers (17) .
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